Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer

Cancer Letters(2023)10.1016/j.canlet.2023.216185Source: DataRank Database

Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer is a research paper published in Cancer Letters (2023). On theSindex it has a DataRank of 0. It has been cited 34 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access34 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (15)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Caitlin Molczyk ORCID,Abhilasha Purohit,Sugandha Saxena ORCID,Reegan Sturgeon ORCID,Bhavana J. Davé ORCID

Live enrichment

PubMed:37062329 PMC:PMC10218365

NCI NIH HHS

Grant: R01 CA228524

NCI NIH HHS

Grant: T32 CA009476

NCI NIH HHS

Grant: P30 CA036727

NCI NIH HHS

Grant: U54 CA163120

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10218365/pdf/nihms-1896577.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0304383523001362?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383523001362?httpAccept=text/plain

MeSH Terms

Cell Line, TumorAnimalsHumansMicePancreatic NeoplasmsReceptors, Interleukin-8AReceptors, Interleukin-8BApoptosisCell Proliferation

Keywords

NeutrophilsAngiogenesisMetastasisPancreatic cancerTumor GrowthCxcr2 Antagonist

Additional file 1 of Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001

10.6084/m9.figshare.25440841.v1figshare

Additional file 1 of Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001

10.6084/m9.figshare.25440841figshare

Additional file 2 of Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001

10.6084/m9.figshare.25441014.v1figshare

Additional file 2 of Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001

10.6084/m9.figshare.25441014figshare